Drug pricing reform has become one of the most discussed strategies for controlling Medicaid costs. As states face rising enrollment, increasing healthcare expenditures, specialty medications, and growing program complexity, policymakers are searching for ways to reduce spending without compromising access
WHY COST AVOIDANCE MUST EXTEND BEYOND DRUG PRICING REFORM
